1st Circuit Reverses Dismissal Of Amphastar, Momenta Antitrust Case

(March 7, 2017, 1:52 PM EST) -- BOSTON — A Massachusetts federal judge’s decision to dismiss allegations that Momenta Pharmaceuticals Inc. made knowing misrepresentations to the U.S. Pharmacopeial Convention (USP) — the standard-setting organization (SSO) charged with ensuring...
To view the full article, register now.